Skip to main content
. 2018 Jul 23;10(7):239. doi: 10.3390/cancers10070239

Figure 8.

Figure 8

Embigin and p21 (CDKN1A) expression in prostate cancer tissue can predict survival. (A) Overall survival determined by Kaplan-Meier analysis of prostate cancer patients with either high or low EMB mRNA expression, (B) high or low p21 (CDNK1A) mRNA expression, and (C) high EMB and low p21 (CDNK1A) mRNA expression or low EMB and high p21 (CDNK1A) mRNA expression.